These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 21249615)
1. Aldosterone producing adrenal adenomas are characterized by activation of calcium/calmodulin-dependent protein kinase (CaMK) dependent pathways. Sackmann S; Lichtenauer U; Shapiro I; Reincke M; Beuschlein F Horm Metab Res; 2011 Feb; 43(2):106-11. PubMed ID: 21249615 [TBL] [Abstract][Full Text] [Related]
2. The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas. Takeda Y; Usukura M; Yoneda T; Oda N; Ito Y; Mabuchi H Clin Endocrinol (Oxf); 2005 Apr; 62(4):504-8. PubMed ID: 15807884 [TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Lenzini L; Seccia TM; Aldighieri E; Belloni AS; Bernante P; Giuliani L; Nussdorfer GG; Pessina AC; Rossi GP Hypertension; 2007 Dec; 50(6):1106-13. PubMed ID: 17938379 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of D2 dopamine receptor and increased protein kinase Cmu phosphorylation in aldosterone-producing adenoma play roles in aldosterone overproduction. Chang HW; Chu TS; Huang HY; Chueh SC; Wu VC; Chen YM; Hsieh BS; Wu KD J Clin Endocrinol Metab; 2007 May; 92(5):1863-70. PubMed ID: 17299068 [TBL] [Abstract][Full Text] [Related]
5. WNT/β-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production. Berthon A; Drelon C; Ragazzon B; Boulkroun S; Tissier F; Amar L; Samson-Couterie B; Zennaro MC; Plouin PF; Skah S; Plateroti M; Lefèbvre H; Sahut-Barnola I; Batisse-Lignier M; Assié G; Lefrançois-Martinez AM; Bertherat J; Martinez A; Val P Hum Mol Genet; 2014 Feb; 23(4):889-905. PubMed ID: 24087794 [TBL] [Abstract][Full Text] [Related]
7. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals. Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131 [TBL] [Abstract][Full Text] [Related]
8. G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism. Ye P; Mariniello B; Mantero F; Shibata H; Rainey WE J Endocrinol; 2007 Oct; 195(1):39-48. PubMed ID: 17911395 [TBL] [Abstract][Full Text] [Related]
9. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways. Saha S; Bornstein SR; Graessler J; Kopprasch S Cell Tissue Res; 2012 Apr; 348(1):71-80. PubMed ID: 22331364 [TBL] [Abstract][Full Text] [Related]
10. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas. Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935 [TBL] [Abstract][Full Text] [Related]
11. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003 [TBL] [Abstract][Full Text] [Related]